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55~ Aortic Root Growth In Children With Marfan 
Syndrome 
M. Groonlnk, L, Rozendaal, M,S+ Naoff, R,C, Honnokam, A.A, Hell, 
E,E, van dor Well, B,J, Muldor, The Academic MedicAl Center, Amsterdam, 
The Nether/ands 
Aim of the Study; To study the cllnlsel significance of aortic root growth on 
diagnosis and prognosis In children with Madsn syndrome, 
Method.q: Serial ochocardlographls sortie root measurements of 123 sub, 
loots (57 Msdan, 06 Control), age 1-20 yearn, attending Marten screening 
from 1983 ta 1996, wore used to construct Individual ~ortto root growth curves 
ralattve to body eudacn area (BSA), By me(me of n Fisher dlsQrlmlnant nnaly. 
~ls two ~ets of parameters, dossrlbing variation In Intemept nnd elope In each 
group, ware call, ulster, With the aid of those psrnmotem ~nd Individual aortic 
root growth charactorlstlce n discrimination scare por subte¢t was calculated, 
This ~coro was tasted to predict both the dlngnosls 'Msdan syndrome' and a 
10-year complication free interval for patients with n discrimination ,cora - 2 
and ~'~2, 
Ft~olfs: Tho monn aortic root growth in the Madan group differed slgnlli. 
gently from the controls (y ,. 13,4x I 14,5 nnd y ,~ 013x t 1~.1 respectively, 
P . 0,0gl) (Fig, t), Sen~ttlvlty and speolftclty of th0 score to predict the 
dlngno~t~ M¢td,~n syndrome was 84% and 73% respectively with three serial 
moas~roments, During 1g-year to,ow.up the o~tim~ted pmbabd=tios of no 
complications were 90% (SE ,~ 9%) for the Boom -, 2, nnd 56% (SE = 13%) 
for the score ~2, P ~ fi069 (Fig, 2) 
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Conclusions. Aortic root growth analysis in chddron may be uselul lor 
early idontlficetion otMadan syndrome and ask stratification 
I 1014-1561 Heterogeneous Response In the Aort ic Root 
Eieatle Properties to Long Term/3-Blockade In 
Patients With the Marfan Syndrome 
A, Rigs, E, Silber, D. Lieb, N. Bavlshi, P, Va~a, B, Burton, W. Clark, 
P Dongs. Michael Reese Heap. ChicAgo, IL, USA 
Purpose: This study was undertaken to assess the effect ot long-term 
t~-blockade on the Ao root stiffness index and distensibility in patients (pts) 
with the Maffan Syndrome. 
Methods: Ao mot stiffness index and distensibility were calculated accord- 
ing to Stefanadi's and Hirai's formulas respectively, using 2D guided M-mode 
echocerdiogram before and after an averego of 26 months on atonoloL 
Results: Twenty three asymptomatic pts were studied (11 M & 12 F; age 
31 ~: 14.2 yrs) with a mean follow-up of 4 yrs. The dose of atenolol was 
individualized (mean 50 ~ t2.5 mg}, Distensibility increased from 1.85 
0.70 to 2.21 ~ 0.76 × 10 6 cm2/dynes (p < 0.02) and the stiffness index 
decreased from 9.68 ~ 3.78 to 8.85 ~ 3.15 (p = 0.2). Two groups of respr)nses 
to treatment were identified: 15 pts (65%), the responders, had increased 
distensibility and decreased stiffness index ot the Ao root (p < 0.05); 8 pts 
(35%), non-responders, had no significant change, Body wt of 200 Ib and 
baseline end-diastolic Ao root diameter ~-.~'3 mm were significantly ~:ssociated 
with no response (p < 0.05), Two pts in the group ot non-responde;~, had 
an ochocardiographic progression in the degree of aortic insufficiency but 
remained clinically asymptomatie.. 
Conclusion~" There was a heterogeneous response m the Ao root elastic 
properties after long-term treatment with atenolol in asymptomatic pts with 
Marfan Syndrome. Individualized ose according to Ao root end diastolic 
diameter and body wt are suggested. 
1014-157 ] Exercise With Non-obstru©tive Capacity 
Hypertrophic Cardlomyopathy: Relation to 
Oiestoll¢ Function In Children 
A,T, Yetmen, B,W, McCrindlo, R,M, Gow. The HospitAl for Sick Children, 
Unlvorslfy of Toronto, CAnada 
BAckground: As exorcise tolerance in chlldran with hyporlrophlc ¢ardiomy- 
opathy (HCM) is unknown, we sought to evAtuate eerobtc capacity and its 
relations to dlAetolla function in children, 
Methods: Cerdlopulmonsry exercise testing end echo were perch"nod in 
11 esymptomnfln petients with HCM with normal WMelio function end ranting 
LV outflow gradients of .~25 mmHg, Median age at evnluetion was 13,5 yr 
(range, 8,6 to 17 yr), Doppler echo indicme of dinstolio funQfton were related 
to maximal oxygen consumption (MVO~) end nneor0bie threshold, Diasto!io 
dysfunction (DDFN) was defined ns isovolumie relaxation time (IVRT), do- 
celoretlon lime lOT) or n/o mitral diastolic inflow velocity +title >~ SD'e a~ve 
predicted normal for ago, 
Results: DDFN wan noted in 6 patients (54%), with longer mean IVRT 
(106 t5 msoo vs, 69 + 14 msec without DDFN; p = 0,002). There were 
no stgnifionnt differences regaling weight, LVOT gradient, seplal thickness 
or Itearl rate, Compared to ago and sea.matched n0Pmats, patients w!th vs. 
without DDFN had lower % predicted MVO2 (68 :r 17% vs 95 z 7%; p = 
0.01) and lower % predicted nnaorabic thmt~hold (85 ~ 24% vs. 117 t t4%; 
p = 0,03)~ Systolic BP wtlh peak ex0mise rose less in those with DDFN (23 
t 17 vs. 00 t 26 mmHg; p ~ 0.01) O~ygen pulse (stroke volume X ave2 
difference/heart ate) was lower in those with vs. without DDFN (8 ~ 3 vs 13 
3; p =~ 0,02). 
Concl41sion" Diastolic dysfunction in associated with reauced exorcise ca- 
pacity tn asymptomstic hildren with non-obstuctive hypedroph,c ardiomy- 
opathy, 
tl Etiology and Fam,y ot   .tr,c 
- - -  Cardiomyopathy: The Early Pediatric 
Cardlomyopathy Registry (PCMR) Experience 
S.E, Lipsbuffz, J.A. Towbtn, M.A. Grenier, V. Osganian, S.D Colon, 
L. Sleeper, R. Shoddy, G, Cox, P. Lurie. Univetsi~/o! Rochester M~edtcal 
Center, Rochester, NY, TexAs Ch#dren's Hospital. Houston, TX, USA 
Background: To better charactenze cardiomyopathy (CM) in children, the 
NHLBl.eponsomd PCMR conducted astudy o1 chddmn with newly dmgnosed 
CM since 1/90. 
Methods: From 8/96-8/97, 1093 eligible chddmn were enrolled at 44 con- 
tom, representing 730 retrospective cases and 363 pmspeclivety identdied 
cases. 
Results: The overall group had a mean age at diagnosis ot 5.7 ± 60 yrs 
with a mean ot 3.1 t 2,1 yrs ot follow-up. 58% were male, possible reflecting 
x-linked CM, LV systolic pedermance was depressed (FS -. - 2 sd) tn 59% ot 
pts. LV dilatation (EDD -2 sd) was noted in 53% ot pts. Thickened LV walls 
(posteNor wall thickness >2 sd) was noted m 29% of pts. Only 21% had a 
known etiology for their CM, a figure that is tower than the 43% reported m 
a 1993 survey ot pediatric ardiologists. Among PCMR children with known 
etiology, we have observed a broad spectrum o1 genetic causes: neuromus- 
cular disorders associated with CM (385%). isolated CM (184%), inborn 
errors ot metabolism (19.5%), mafformation syndromes associated with CM 
(10,3%) and not specified (13.2%). Among 255 pts with supplemental PCMR 
data, many had first-degrse relatives with CM (27%), sudden death (13%). 
congenital heart detects (9%), arrhylhmias (3%), or recognizable genetic syn- 
dromes (7%). The incidence of familial disease ot potential relevance was 
higher than expected, occurring in 40% of CM pts. 48% of PCMR pts had 
an ICU admission for CM and 56% ot all pIs are on antieongestive therapy. 
Other therapies reported included 22% ar,tiarrhythmic, 41% ACE inhibitor. 
11% calcium antagonist, 11% beta adrenergic antagonist, 19% camitine. 3% 
pacemaker, and 12°o dietary modification. 
Conclusion: Even at centers with interest in pediatric CM, the incidence 
of CM without a known etiology is surprisingly high. Our data suggests that 
genetic contributions to pediatric CM are likely to be underestimated. 
[ 1 01 4-1 59]  Left Ventricular Noncompaction: Evidence for a 
Mitoohondrlal Etiology 
D. Stromb~rg, RJ. Gaja~ki, V. Exil, A. Strauss, R.H. PignatellL 
S.W. Denfield, J.K. Price, S. Lipshuffz, J.A. Towbin. Bay/or College of 
Medicine. Houston, Texas, USA 
Back~)lound. Lett ventricutar noncompaction (LVNC) is rare type of cardiomy- 
.~pothy which generally occurs in infants and leads to congestive heart failure. 
Characteristic echocardiographic findings include deep trabeculations within 
the left ventricular endocardium, with chamber dilation and/or hypertrophy. 
Associated cardiac lesions such as ventricular septal detect (VSD) and pul. 
menlo stenosis are common. Though the etiology ot LVNC with associated 
JACC I:chnian 1~)98 ;~HS'I'IL+%('I ~ - l ' ,,, i~ "~1/tl 
card*ac anomatios ~,~ cunently unknown, isolated LVNC has been shown to 
occur with X.linked inhentanco and mutations in the taffazin (G45) gone and 
protein The purpose of th~s teporl is to desenba the ¢1in¢~1 findings of LVNC 
with VSD in two children which suggest a possible etiology different from that 
of iSO!a|(~ LVNC 
M~tf~:  TwO neonates who prosentnd with heart taduro were identified 
by echoc~lrdiography as hawng LVNC with associated VSD Subsequent 
clintc,~l work-up employed the Pediamc Cardiomyop~thy RegistW diagnos- 
tm a~nlhm which included evaluation o! serum el~rolytes, eamltine and 
aolt-eamitiea profiles, aotl.CeA dehydfogenases, serum am,no acids, unne 
organic acids, and skeletal muscle I~opsy, with of without endomyocardtat 
b~psy, for hislology, e!O~-'tron mzcfos¢opy (EM), msl~mtory chain enzyme 
analysis, and mitochondtial DNA (mtDNA) mutation screen 
Re.~ulP3. In both patlenls (2 female~) skelefa! muscle biopSy demonstr~t ~) 
abnolma! mltt~bendnal nund~er a!~! ~ppeam~ by histology and EM (one 
patient) bad intran.tochondnal inctusions), consistent with e mitochonclnal 
proliferative d~sea~lo+ Enzyme stainin~ Showed a r~J~++ticn of cytochrom~ 
omdase. No mutabons in G45 were Identified. Analysis for mtDNA mut-llons 
IS currently tmderway 
Conctusmn: LVNC wffh V$13 is assooeted with abnormal m~tochondna 
and m, tochondna! resp~ralely chain abnormatibes. Tbemfore, LVNC appears 
to be frenetically hEterocjeneous. Sl:~Clhc mtDNA mutations respenmble for 
the chscrder am 13elqg sought 
I 1014-160] Outcome of Infantile Familial Dilated 
Cardlomyopathy. Comparison With the 
Non-fami l ia l  D isease  in Pediatr ic Age Group 
M A. Set/am. K.B. Manasra, M. Pahleo. ARAMCO Dhahran Hea#h Center. 
Dhahran, Sauo~ Arabia 
O ~ :  TO desc~nbe the natural h~ston/of famdial Idiopathic D=alated Car- 
ckomyopathy (IDCM) presenting in intatqcy and to compare its clinical course 
w~th the non-famdlal form of IDCM 
Bac~gn~und: Familial eh~togy of IDCM has been reported repeatedly 
among (bfferent age groups. The outcome of this dmhnct form of IDCM when 
presents exclusively in inta~:y has not b~on descnbed. 
Methods; Four famdms with a total of 17 cases of IDCM who presented 
before two years ol age are the focus of this study. Each fam, ly has at least 3 
affected sibhngs. No~e of the~e petmnts (Pts.) has any co~:jenrtal or acquired 
head dF~ease. The ctin¢cal CouP3e of these mfant~ was compared wr~ that of 
38 ~ v e  children wdh IDCM 
Echo~rdiogrephy was the main modal~,, for chagnosis and follow-up 
None of these Pts. underwent heart transplantation Medical therapy was the 
only treatment offered. 
Re~ul~s All cases of fami!ial InCM presented before 2 years of age Four- 
leon ut mere u~eo a;.;c ~r-tore 2 yea~ of age ttctal modality 88<'=) There 
was no difference boh'.'een these famd~al cases and non-farad=at ones =n sex 
dcstnbubon, age at diagnoszs, location o! referral, preceding viral mfect~on. 
echocard=ograph~c LV shortening fraction on presentation, conventional drug 
therapy, usage of steroids. }.-globulins or B-Blockers. Acute IV inotropics and 
long term vasoddators were used much more in familial cases (P = 003 ano 
0.006 respectively). The rnalor difference between the two groups, however. 
was sun/ival; 2~17 (12%) among familial cases versus 28/38 (74%) of non- 
familial cases. P - 0.0001. Among non-familial cases. LV systolic function 
returned to normal in 37% ot the cases ~,~thin 6 months of presentahon and 
remained abnormal in 37% of them up to the latest follow up. 
Conc/usrons: Familial IDCM (30% of IDCM cases in our pediatnc popu- 
lation) carnes a very poor prognosis when presents in infancy. Heart trans. 
plantation (H. Tx,) should be considered as soon as possible once diag- 
nosis is made. The non-tamilial disease has 74% probability of survival 
Therefore aggressive medical therapy should be attempted before H. Tx. is 
sought. 
•0• Modal/ties in Heart Fai!ure Treatment 
Sunday, March 29, 1998, 5:00 p.m.-7"00 p,m. 
Georgia World Congress Center, West Exhibit Hall Level 
Presentation Hour: 5:00 p.m.-7:00 p,rn. 
~ Ventricular in Patients With Dilated Funct ion  
Card iomyopathy  is Improved by VDD Pacing at  
Left but  Not  R ight  Ventr icu lar  Sites 
D.A. Kass, C.-H. Chert, B. Fetics, M. Talbot. E. Nevo. M. Nakayama. Johns 
Hopkins Unwersi~ Baltimore MD. USA 
Background: Ventncular pre-excitahon by VDD pacing with a shod AV delay 
is a potential therapy for patients with dilated heart failure (DCM). However. 
th0 optrmat paczng szto may not I~ 1~o nghl ventnculat apex ~s ,s mostly 
w~G~ely employ(~l 
MethOcl~: Cardiac c~thatonzatlon by pressure-volume an~lys~s wa~ per, 
formed in 14 pts with DCM (NYHA.II!-!V. me~lrt EF 19 .~ 2%i Base!ins QR$ 
and PR .ntervals were t47 ~ g 2 ms and 207 ~ 21 ms, respeettvety VDD 
I:~lcm9 was perfon/~d with activation at the RV apex (RVA), rf~d RV septum 
(RVS), LV base (LV~, vi~ coroea~ veno~s p~ctng wire), of b~,~ntn¢~r (RVA 
* LV) Steady.state d~t~ measured pnof to and t ~2 mm a~et the onset of 
pacing were recorded 
Results: Only VD_O p~c,n~ I at the LVB induce(~ slgn!f~..ant changes m LV 
syslotic function, if~|e~ti!~l by a n,~e In peak pressure (Psys) ar~ m~L~k,~al 
pressure (~nvative (d~/dt~,) 
FIVA RV~ LVB RVA * LV 
Psys 27 ~ 20 (~7 ~ 09 73 t 1 t 'tr 23 ,- I 7 
Datalr~tai~heare%~% i e, emfromsmusm~thmNSR.',p, O001veNSR t p, 00t 
vsRVA ! -p 001 vsR~S 
Results with biventncutaf pacing were worse than wrlh single-site LV 
pacing PV loops obtruded in a subset of patients were consistent with these 
(~la. The contractile response to pacing s~gncfmantly correlated w~th baseline 
ORS duration (p = 0.00~), mdcatmg the importance of electro-mechanical 
a~:tivatio. ¢~,;.~y lu tim re,~po~,se 
Conctusmns. VDD pacing can substantmlly =mprove LV systolic functlon 
~n DCM patients, but this effect depends upon the site of actwatlon, LV pacing 
m preferable over RV or bwenmcular pacing 
• Cl in ica l  and Object ive improvements  in Severe 
Congest ive  Heart Fai lure Pat ients Using 
Univentricular or Blventricular Pacing: 
Preliminary Results of a Randomized Prospective 
Study 
A. Auncch~o. C. 3tel:bnnk. M Block, P Modensen. On Dehalf of the 
PATH-CHF fnvest~gators: Unevetsdy Hospital Magc/eburg. Germany 
I ~ n ;  Prewous non-randomized studms evaluating pacing therapy in 
severe congestive heart failure (CHF) have reported conflicting results. The 
"PATH-CHF" (PAcing THerapy in CHF) study is a prospestwe mu~center 
study companng umventncular (Urn), i.e. right (RV) or lefl ventncular (LV) 
s~mulabon, to bnrentncular (BN) paong in patients (pts) with severe CHF 
Matt.:/s: After implant of 2 pacemakers, each pt was randomized m a 
cross-over study, including 4 weeks of Um pacing and 4 weeks o! RN pacing 
separated by a wash-out penod Optimal Um pacmg mode and AV delays 
were selected by extensive mtraoperatwe test 
Results. The study included 16 pts with @lated congestwe cardtomyopathy 
of any ongl=, stable NYHA Ill/IV. PR mten~al • 150 ms and ORS duration 
• 120 ms. Mean age was 59 ~ 5 yrs. Mean LV elation fraction was 22 ± 7% 
Changes in NYHA class, quality-of-life tOOL), 6-minute walking test (6-mm), 
maximal work rate (WR) and VO2 at anaerobic threshold (AT VO~) are listed 
below 
Pre-lmplant Um BIV p varue 
NYHA 33:03  15~05 14=04 -0001 
QOL (Mlnnesc, ta score) 54 .- 16 25 = 22 12 = 15 ~ 0001 
6-m.,n (m) 295=61 375=106 410 ~ 64 -001 
WR tWans) 62 ++ 21 92 : 42 90 ~ 40 - 0 05 
AT VO2 t mL kg.,rnm) 90 :13  117t25 134~25 -005 
P values re|el5 to comparison between !)m +3rid BIV ,..s Pre-fn~t~tt~ 
Conclusions: These data demonstrate significant short-term objectrve ,m- 
provement dunng Um or B~V pacing in selected CHF pts. Long.term foflow-up 
will allow confirmation of these early findings. 
i1015-31 i Excellent Effect on Left Ventrlcular Despite an J Performance, Carvedilel Falls to Improve the 
Pulmonary Function and Peak Exercise 02 
Uptake  in Chronic Heart Failure. Any  Link? 
M GuazzL P.G. Agostoni. N. TtLm,qsi. M.D. Guazzi. Institute of Cardtolog~ 
University of Mdan. CN R . Mdan. Italy 
Background: Disturbances in ventilation and in pulmonary gas transfer (stress 
failure of alveolar-capillary membrane) due to chronic head fadure (CHF). 
participate in limiting peak exercise oxygen uptake (pVO2). This study was 
aimed at investigating the effects of carvedilol on lung function in CHF. as ~t 
improves left ventdcular dysfunction and not pVO2 
Methods: 21 NYHA class I1-111 pabents given digoxin and furosem~de. 
were randomized (two t'~ one) to ca~,~ilol (25 mg I0 d !4 pts) or placebo (7 
